PUBLISHED DATE : Nov 2020 | Pages : 213
Fill out your details & get your free sample
Left Atrial Appendage (LAA) Closure Devices Market Size, Share, & Trends Analysis Report by Product (Endocardial and Epicardial LAA closure), End-users (Hospitals, Specialty Cardiac Centers, and Ambulatory Surgery Centers (ASC)), and Geography (APAC, Europe, North America, Latin America, and Middle East & Africa), Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020–2025
213 Pages
28 Tables
110 Charts
5 Regions
18 Countries
8 Companies
3 Market Segment
| Report Attribute | Details |
|---|---|
| MARKET SIZE (REVENUE) | USD 3 BILLION (2025) |
| CAGR | 36% (2020-2025) |
| Base Year | 2019 |
| Historic Year | 2018 |
| Forecast Year | 2020-2025 |
| Market Segments | Product (Endocardial and Epicardial LAA closure), End-users (Hospitals, Specialty Cardiac Centers, and Ambulatory Surgery Centers (ASC)) |
| Geographic Analysis | APAC, Europe, North America, Latin America, and Middle East & Africa |
| Countries Covered | US, Canada, Germany, France, UK, Italy, Spain, Japan, China, India, South Korea, Australia, Brazil, Mexico, Argentina, Turkey, Saudi Arabia, and South Africa |
Left atrial appendage (LAA) closure devices market size to reach USD 3 billion by 2025, growing at a CAGR of 36% during the forecast period. The left atrial appendage (LAA) closure devices market growth can be attributed to the growing prevalence of atrial fibrillation (AF) across the globe. The growth in the geriatric population and the increased prevalence of lifestyle-related disorders such as obesity, diabetics, and high blood pressure are contributing to the growth of AF. According to several epidemiological studies, AF is the most common arrhythmia, with an estimated prevalence of 1.5–3% in the general population in developed regions. Approximately 7.6 million people over 65 years of age in Europe suffered from AF in 2016, which is expected to increase by around 89%, reaching 14.4 million by 2060. Hence, the high occurrence of AF across the globe is likely to contribute to the growth of the market.
In addition, frequent development and commercial approvals & launches of innovative next-generation LAA closure devices is another primary factor driving the rising uptake of these devices worldwide. For instance, market leader Boston Scientific received CE Mark approval for its Next Generation WATCHMAN FLX Left Atrial Appendage Closure Device in March 2019.
This research report includes a detailed segmentation by
The endocardial LAA closure devices segment accounts for the maximum shares as these devices are safe and effective. Several clinical studies conducted on endocardial devices have displayed encouraging results for the patient population in terms of stroke risk reduction, thereby contributing to the market share of the segment. Endocardial devices involve a lower complication rate (around 8.5%) compared with epicardial devices (25.4%), which is likely to boost the segment growth.
The surgical epicardial LAA closure devices have emerged as an alternative procedure for LAA closures intending to improve efficacy, particularly for the patients that have displayed poor results for the standard endocardial technique. In 2019, the epicardial segment accounted for 17% of the global market share.
The hospitals segment is accounted for major share of 55% in 2019. Healthcare professionals in the hospital segment use advanced LAA closure devices, including endocardial and epicardial, to treat AF. The segment is growing at a healthy rate, which is expected to continue during the forecast period. The growth in the aging population and the increasing pool of AF patients are the major factors driving the segment growth.
The specialty cardiac centers (SCC) segment provides exclusive healthcare services to patients with suspected or diagnosed cardiac diseases. These centers are solely dedicated to treating patients suffering from cardiac ailments such as AF. The segment is likely to witness the fastest growth during the forecast period.
The ambulatory specialty center (ASC) segment constitutes a small share of the global left atrial appendage (LAA) closure devices market. These centers are cost-effective and offer quality care with the minimal indirect cost of treatment. The segment is expected to witness significant growth, especially in developed countries.
North America dominates the global left atrial appendage (LAA) closure devices market share. North America is likely to witness highest CAGR of 38%. The presence of a large disease population, coupled with better treatment options for AF, is the primary factor for the high market share. The US is the major revenue contributor to the North America region and accounted for a share of 98% in 2019.
Germany, France, the UK, Spain, and Italy are the major revenue contributors. The market in Europe is expected to grow at a healthy rate during the forecast period. Western Europe has advanced healthcare services, especially for the implantation of LAA closure devices. The increasing incidence of AF, the rapid adoption of advanced devices, and high healthcare expenditures are driving the growth in Europe.
APAC accounted for the third largest share in 2019. China, Japan, Australia, South Korea, and India are the major revenue contributors in the APAC region. A high disease prevalence population, improvement in healthcare spending, and an increase in awareness for heart diseases, including AF, will fuel the growth of the left atrial appendage (LAA) closure devices market in the region.
The global left atrial appendage (LAA) closure devices market is highly consolidated and is characterized by the presence of a few established players holding a majority of the shares. Vendors are offering several endocardial and epicardial devices and are competing based on factors such as technology, safety features, regulatory approvals, marketing strategies, and distribution channels. Boston Scientific, AtriCure, and Abbott are the key vendors in the market.
Market Segmentation by Product
By End-user
By Geography
Frequently Asked Questions
Left atrial appendage (LAA) closure devices market size to cross USD 3 billion by 2025, growing at CAGR of 36% during forecast period.
What is the growth of the adult and pediatric segment by 2025?
The specialty cardiac centers (SCC) segment provides exclusive healthcare services to patients with suspected or diagnosed cardiac diseases. These centers are solely dedicated to treating patients suffering from cardiac ailments such as AF. The segment is likely to witness the fastest growth during the forecast period.
Who are the major players in the market and what are their market shares?
The key vendors are: V Boston Scientific, AtriCure, Abbott, Biosense Webster, Lifetech Scientific, SentreHEART
The hospital end-user segment is expected to account for $1.6 billion incremental growth due to the large uptake of advanced LAA closure devices in several private and public hospitals across the globe.
How is the growing population in the Asia Pacific region impacting the growth of the market?
APAC accounted for the third largest share in 2019. China, Japan, Australia, South Korea, and India are the major revenue contributors in the APAC region.
The left atrial appendage (LAA) closure devices market is expected to grow at a staggering CAGR of over 36% during the period 2019–2025.
The following factors are likely to contribute to the growth of the left atrial appendage closure devices market during the forecast period:
Base Year: 2019
Forecast Year: 2020–2025
The study considers the present scenario of the left atrial appendage closure devices market and its market dynamics for the period 2019−2025. It covers a detailed overview of several market growth enablers, restraints, and trends. The study offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent companies operating in the market.
Key Vendors
Other Vendors
Investigational Companies
Market Segmentation by Product
Market Segmentation by End-user
Market Segmentation by Geography
1 Research Methodology
2 Research Objectives
3 Research Process
4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusion
4.2 Base Year
4.3 Scope Of The Study
4.4 Market Segments
4.4.1 Market Segmentation By Product
4.4.2 Market Segmentation By End-User
4.4.3 Market Segmentation By Geography
5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 Market at a Glance
7 Introduction
7.1 Atrial Fibrillation: Overview
7.1.1 Background
7.1.2 LAA Closure Devices For The Treatment Of AF
8 Market Opportunities & Trends
8.1 Emergence Of Advanced Imaging Modalities
8.2 Vendors Increasing Focus On Conducting Clinical Trials On LAA Closure Devices
8.3 Emergence Of Hybrid Approach In LAA Closure Technique
8.4 Promising Investigational LAA Closure Devices
8.5 Strategic Acquisitions
9 Market Growth Enablers
9.1 Rising Incidence Of AF
9.2 Transference From Open To Mi Surgeries
9.3 Frequent Product Approval
9.4 Significant Long-Term Cost Effectiveness Associated With LAA Closure
10 Market Restraints
10.1 High Use Of Oral Drugs
10.2 Complications Associated With LAA Closure Devices
10.3 Stringent Regulations & Product Recalls
11 Market Landscape
11.1 Market Overview
11.2 Market Size & Forecast
11.3 Five Forces Analysis
11.3.1 Threat Of New Entrants
11.3.2 Bargaining Power Of Suppliers
11.3.3 Bargaining Power Of Buyers
11.3.4 Threat Of Substitutes
11.3.5 Competitive Rivalry
12 Product
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
12.3 Endocardial LAA Closure
12.3.1 Market Overview
12.3.2 Market Size & Forecast
12.4 Epicardial LAA Closure
12.4.1 Market Overview
12.4.2 Market Size & Forecast
13 End-User
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Hospitals
13.3.1 Market Overview
13.3.2 Market Size & Forecast
13.4 Specialty Cardiac Centers
13.4.1 Market Overview
13.4.2 Market Size & Forecast
13.5 ASCS
13.5.1 Market Overview
13.5.2 Market Size & Forecast
14 Geography
14.1 Market Snapshot & Growth Engine
14.2 Geographic Overview
15 North America
15.1 Market Overview
15.2 Market Size & Forecast
15.3 Key Countries
15.3.1 US: Market Size & Forecast
15.3.2 Canada: Market Size & Forecast
16 Europe
16.1 Market Overview
16.2 Market Size & Forecast
16.3 Key Countries
16.3.1 Germany: Market Size & Forecast
16.3.2 France: Market Size & Forecast
16.3.3 UK: Market Size & Forecast
16.3.4 Spain: Market Size & Forecast
16.3.5 Italy: Market Size & Forecast
17 APAC
17.1 Market Overview
17.2 Market Size & Forecast
17.3 Key Countries
17.3.1 China: Market Size & Forecast
17.3.2 Japan: Market Size & Forecast
17.3.3 Australia: Market Size & Forecast
17.3.4 South Korea: Market Size & Forecast
17.3.5 India: Market Size & Forecast
18 Latin America
18.1 Market Overview
18.2 Market Size & Forecast
18.3 Key Countries
18.3.1 Brazil: Market Size & Forecast
18.3.2 Mexico: Market Size & Forecast
18.3.3 Argentina: Market Size & Forecast
19 Middle East & Africa
19.1 Market Overview
19.2 Market Size & Forecast
19.3 Key Countries
19.3.1 Turkey: Market Size & Forecast
19.3.2 Saudi Arabia: Market Size & Forecast
19.3.3 South Africa: Market Size & Forecast
20 Competitive Landscape
20.1 Competition Overview
20.2 Market Share Analysis
20.2.1 Boston Scientific
20.2.2 AtriCure
20.2.3 Abbott
21 Key Company Profiles
21.1 Boston Scientific
21.1.1 Business Overview
21.1.2 Product Offerings
21.1.3 Key Strategies
21.1.4 Key Strengths
21.1.5 Key Opportunities
21.2 AtriCure
21.2.1 Business Overview
21.2.2 Product Offerings
21.2.3 Key Strategies
21.2.4 Key Strengths
21.2.5 Key Opportunities
21.3 Abbott
21.3.1 Business Overview
21.3.2 Product Offerings
21.3.3 Key Strategies
21.3.4 Key Strengths
21.3.5 Key Opportunities
22 Other Prominent Vendors
22.1 Biosense Webster
22.1.1 Business Overview
22.1.2 Product Offerings
22.1.3 Key Strategies
22.1.4 Key Strengths
22.1.5 Key Opportunities
22.2 Lifetech Scientific
22.2.1 Business Overview
22.2.2 Product Offerings
22.2.3 Key Strategies
22.2.4 Key Strengths
22.2.5 Key Opportunities
22.3 SentreHEART
22.3.1 Business Overview
22.3.2 Product Offerings
22.3.3 Key Strategies
22.3.4 Key Strengths
22.3.5 Key Opportunities
23 Investigational Companies
23.1 Append Medical
23.1.1 Business Overview
23.1.2 Key Strategies
23.1.3 Key Strengths
23.1.4 Key Opportunities
23.2 Cardia
23.2.1 Business Overview
23.2.2 Key Strategies
23.2.3 Key Strengths
23.2.4 Key Opportunities
24 Report Summary
24.1 Key Takeaways
24.2 Strategic Recommendations
25 Quantitative Summary
25.1 Product
25.2 End-User
25.3 Geography
26 Appendix
26.1 Abbreviations
List Of Exhibits
Exhibit 1 Segmentation of Global LAA closure devices Market
Exhibit 2 Market Size Calculation Approach 2019
Exhibit 3 Most Common Signs & Symptoms of AF
Exhibit 4 Irregular Heartbeat Associated with AF
Exhibit 5 Overview of the LAA Closure
Exhibit 6 Types of LAA Closure
Exhibit 7 Global LAA Closure Devices Market Snapshot
Exhibit 8 Global LAA Closure Devices Market by Geography 2019 (%)
Exhibit 9 Global LAA Closure Devices Market by Product 2019 (%)
Exhibit 10 Impact of Emergence of Advanced Imaging Modalities
Exhibit 11 Key Advantages of TEE over Cardiac MRI and CT
Exhibit 12 Key Potential Additional Value of 3D TEE vs. 2D TEE
Exhibit 13 Impact of Vendors Increasing Focus on Conducting Clinical Trials on LAA Closure Devices
Exhibit 14 Impact of Emergence of Hybrid Approach in LAA Closure Technique
Exhibit 15 Key Benefits of One-stage Hybrid LAA Closure Procedure
Exhibit 16 Impact of Promising Investigational LAA Closure Devices
Exhibit 17 Impact of Strategic Acquisitions
Exhibit 18 Impact of Rising Incidence of AF
Exhibit 19 Mortality Rate of Atrial Fibrillation among Men in Developing & Developed Countries 1990−2015 (Per 100,000 population)
Exhibit 20 Age-adjusted prevalence of Atrial Fibrillation Among Men & Women in Developing & Developed Countries (Per 100,000 population)
Exhibit 21 Recommended Patients for LAA closure Devices
Exhibit 22 Anticoagulation Use Declines with Increased CHADS2 Score
Exhibit 23 Impact of Transference from Open to MI Surgeries
Exhibit 24 Key Benefits of Using MI LAA Closure Approach
Exhibit 25 Impact of Frequent Product Approval
Exhibit 26 Impact of Significant Long-term Cost Effectiveness Associated with LAA Closure
Exhibit 27 Total Cumulative Cost for LAA Occlusion vs. Warfarin at 1st Year Compared to 10th Year ($)
Exhibit 28 Impact of High Use of Oral Drugs
Exhibit 29 Most Commonly Used OATs
Exhibit 30 Ideal Patient Care Pathway for AF Patients
Exhibit 31 Impact of Complications Associated with LAA Closure Devices
Exhibit 32 Type of Common Complications Associated with Percutaneous LAA Closure
Exhibit 33 Impact of Stringent Regulations & Product Recalls
Exhibit 34 Major Actions/Sanctions Imposed on Manufacturers by Regulatory Bodies
Exhibit 35 Global LAA Closure Devices Market 2019–2025 ($ million)
Exhibit 36 Global LAA Closure Devices Market by Geography
Exhibit 37 Global LAA Closure Devices Market by Product
Exhibit 38 Global LAA Closure Devices Market by End-user
Exhibit 39 Five Forces Analysis 2019
Exhibit 40 Incremental Growth by Product 2019 & 2025
Exhibit 41 Global LAA Closure Devices Market by Product
Exhibit 42 Global LAA Closure Devices Market by Product: Incremental Growth
Exhibit 43 Global LAA Closure Devices Market by Product: Absolute Growth
Exhibit 44 Global Endocardial LAA Closure Devices Market: Incremental & Absolute Growth
Exhibit 45 Global Endocardial LAA Closure Devices Market 2019–2025 ($ million)
Exhibit 46 Global Epicardial LAA Closure Devices Market: Incremental & Absolute Growth
Exhibit 47 Global Epicardial LAA Closure Devices Market 2019–2025 ($ million)
Exhibit 48 Incremental Growth by End-user 2019 & 2025
Exhibit 49 Global LAA Closure Devices Market by End-user
Exhibit 50 Global LAA Closure Devices Market by End-user: Incremental Growth
Exhibit 51 Global LAA Closure Devices Market by End-user: Absolute Growth
Exhibit 52 Global LAA Closure Devices Market by Hospitals: Incremental & Absolute Growth Comparison
Exhibit 53 Global LAA Closure Devices Market by Hospitals 2019–2025 ($ million)
Exhibit 54 Global LAA Closure Devices Market by Specialty Cardiac Centers: Incremental & Absolute Growth Comparison
Exhibit 55 Global LAA Closure Devices Market by Specialty Cardiac Centers 2019–2025 ($ million)
Exhibit 56 Global LAA Closure Devices Market by ASCs: Incremental & Absolute Growth Comparison
Exhibit 57 Global LAA Closure Devices Market by ASCs 2019–2025 ($ million)
Exhibit 58 Incremental Growth by Geography 2019 & 2025
Exhibit 59 Global LAA Closure Devices Market by Geography
Exhibit 60 Global LAA Closure Devices Market by Geography 2019: Key Countries ($ million)
Exhibit 61 Global LAA Closure Devices Market by Geography: Incremental Growth
Exhibit 62 Global LAA Closure Devices Market by Geography: Absolute Growth
Exhibit 63 North America LAA Closure Devices Market in 2019
Exhibit 64 North America LAA Closure Devices Market: Incremental & Absolute Growth Comparison
Exhibit 65 LAA Closure Devices Market in North America 2019–2025 ($ million)
Exhibit 66 Incremental Growth in North America 2019 & 2025
Exhibit 67 LAA Closure Devices Market in US 2019–2025 ($ million)
Exhibit 68 LAA Closure Devices Market in Canada 2019–2025 ($ million)
Exhibit 69 Europe LAA Closure Devices Market in 2019
Exhibit 70 Europe LAA Closure Devices Market: Incremental & Absolute Growth Comparison
Exhibit 71 LAA Closure Devices Market in Europe 2019–2025 ($ million)
Exhibit 72 Incremental Growth in Europe 2019 & 2025
Exhibit 73 LAA Closure Devices Market in Germany 2019–2025 ($ million)
Exhibit 74 LAA Closure Devices Market in France 2019–2025 ($ million)
Exhibit 75 LAA Closure Devices Market in UK 2019–2025 ($ million)
Exhibit 76 LAA Closure Devices Market in Spain 2019–2025 ($ million)
Exhibit 77 LAA Closure Devices Market in Italy 2019–2025 ($ million)
Exhibit 78 APAC LAA Closure Devices Market in 2019
Exhibit 79 APAC LAA Closure Devices Market: Incremental & Absolute Growth Comparison
Exhibit 80 LAA Closure Devices Market in APAC 2019–2025 ($ million)
Exhibit 81 Incremental Growth in APAC 2019 & 2025
Exhibit 82 LAA Closure Devices Market in China 2019–2025 ($ million)
Exhibit 83 LAA Closure Devices Market in Japan 2019–2025 ($ million)
Exhibit 84 LAA Closure Devices Market in Australia 2019–2025 ($ million)
Exhibit 85 LAA Closure Devices Market in South Korea 2019–2025 ($ million)
Exhibit 86 LAA Closure Devices Market in India 2019–2025 ($ million)
Exhibit 87 Latin America LAA Closure Devices Market in 2019
Exhibit 88 Latin America LAA Closure Devices Market: Incremental & Absolute Growth Comparison
Exhibit 89 LAA Closure Devices Market in Latin America 2019–2025 ($ million)
Exhibit 90 Incremental Growth in Latin America 2019 & 2025
Exhibit 91 LAA Closure Devices Market in Brazil 2019–2025 ($ million)
Exhibit 92 LAA Closure Devices Market in Mexico 2019–2025 ($ million)
Exhibit 93 LAA Closure Devices Market in Argentina 2019–2025 ($ million)
Exhibit 94 Middle East & Africa LAA Closure Devices Market in 2019
Exhibit 95 Middle East & Africa LAA Closure Devices Market: Incremental & Absolute Growth Comparison
Exhibit 96 LAA Closure Devices Market in Middle East & Africa 2019–2025 ($ million)
Exhibit 97 Incremental Growth in Middle East & Africa 2019 & 2025
Exhibit 98 LAA Closure Devices Market in Turkey 2019–2025 ($ million)
Exhibit 99 LAA Closure Devices Market in Saudi Arabia 2019–2025 ($ million)
Exhibit 100 LAA Closure Devices Market in South Africa 2019–2025 ($ million)
Exhibit 101 Global LAA Closure Devices Market: Vendors Market Share (2019)
Exhibit 102 Boston Scientific: R&D Expenditure 2017−2019 ($ million)
Exhibit 103 Boston Scientific: Revenue by Segments 2018 & 2019 ($ million)
Exhibit 104 Boston Scientific: Revenue by Geography 2019 (%)
Exhibit 105 AtriCure: R&D Expenditure 2017−2019 ($ million)
Exhibit 106 AtriCure: Revenue by Product Segments 2018 & 2019 ($ million)
Exhibit 107 AtriCure: Revenue by Geography 2019 (%)
Exhibit 108 Abbott Revenue 2017−2019 ($ billion)
Exhibit 109 Abbott Revenue Breakdown by Business Segments 2017−2019 ($ million)
Exhibit 110 Abbott R&D Expenditure 2017−2019 ($ billion)
List Of Tables
Table 1 Key Caveats
Table 2 Currency Conversion 2013−2019
Table 3 Major Clinical Studies Conducted by Vendors on LAA Closure Devices
Table 4 Popular Investigational LAA Closure Devices
Table 5 Major Acquisitions in Global LAA Closure Devices Market
Table 6 List of New Product Approval/Launch
Table 7 Cost benefit of LAAC Compared to Warfarin
Table 8 Some LAA Closure Devices & Associated Complications
Table 9 Recent Product Recalls
Table 10 Key Endocardial LAA Closure Devices
Table 11 Key Epicardial LAA Closure Devices
Table 12 Provincial Reimbursement Policy in China
Table 13 Competitive Structure Analysis of Global Left Atrial Appendage Closure Devices Market
Table 14 Global LAA Closure Devices Market: Vendors Ranking 2019
Table 15 Boston Scientific: Major Product Offerings
Table 16 AtriCure: Major Product Offerings
Table 17 Abbott: Major Product Offerings
Table 18 Biosense Webster: Major Product Offerings
Table 19 Lifetech Scientific: Major Product Offerings
Table 20 SentreHEART: Major Product Offerings
Table 21 Append Medical: Investigational LAA Closure Product Offerings
Table 22 Cardia: Investigational LAA Closure Product Offerings
Table 23 Global LAA Closure Devices Market by Product 2019−2025 ($ million)
Table 24 Global LAA Closure Devices Market by Product 2019−2025 (%)
Table 25 Global LAA Closure Devices Market by End-user 2019−2025 ($ million)
Table 26 Global LAA Closure Devices Market by End-user 2019−2025 (%)
Table 27 Global LAA Closure Devices Market by Geography 2019−2025 ($ million)
Table 28 Global LAA Closure Devices Market by Geography 2019−2025 (%)
Single User Licence
5 User Licence
Corporate Licence
Datasheet Licence
"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."
